Stock LSB LAKESHORE BIOPHARMA CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases LakeShore Biopharma Co., Ltd

Equities

LSB

KYG9845F1090

Real-time Estimate Cboe BZX
Other stock markets
 11:01:07 2024-06-04 EDT 		5-day change 1st Jan Change
0.838 USD -5.84% Intraday chart for LakeShore Biopharma Co., Ltd -13.86% +70.25%
05-28 YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS CI
05-24 YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28 MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
YS Biopharma Announces Name Change to LakeShore Biopharma
PR
YS Biopharma Announces Results of Extraordinary General Meeting
PR
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
PR
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
PR
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
AQ
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
PR
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
PR
YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
PR
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
PR
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
PR
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
PR
YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
PR
/C O R R E C T I O N -- YS Biopharma Co., Ltd./
PR
YS Biopharma Announces Appointment of New Directors
AQ
YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance
PR
YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.
PR
YS Biopharma Announces US$40 Million Private Placement Financing
PR
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
PR
YS Biopharma Announces Changes to its Board Committees
PR
YS Biopharma : ANY OTHER PERSON WHO KNOWS OF THIS ORDER AND DOES ANYTHING WHICH HELPS OR PERMITS YI ZHANG TO BREACH THE TERMS OF THIS ORDER MAY ALSO BE HELD TO BE IN CONTEMPT OF COURT AND MAY BE IMPRISONED, FINED OR HAVE THEIR ASSETS SEIZED - Form 6-K
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LSB Stock
  4. News LakeShore Biopharma Co., Ltd
  5. Press Releases